PTCE · Patient Safety and Quality Assurance · 6 min read · Open lesson
Error Prevention: Tall Man Lettering, Zeros and Abbreviations
- Identify the regulatory role of pharmacy technicians under pharmacist supervision when encountering dangerous dose notations, ambiguous abbreviations, or unclear orders.
- Recognize look-alike and sound-alike medication pairs that utilize Tall Man lettering on pharmacy computer order-entry screens, shelf labels, and automated dispensing cabinets.
- Apply safety standards regarding leading zeros, trailing zeros, and prohibited or error-prone abbreviations from The Joint Commission and the Institute for Safe Medication Practices (ISMP).
The Technician's Role and Safety Responsibilities
Pharmacy technicians work under pharmacist supervision, as required by state law, and help prevent medication errors. Technicians serve as an essential line of defense in daily dispensing activities, assisting the pharmacy team while operating within their legal scope of practice.
The pharmacist performs the clinical review and final verification of prescriptions. Technicians assist with technical tasks under pharmacist supervision, subject to applicable state law. These defined boundaries ensure that each prescription is checked thoroughly before reaching the patient.
It is vital to understand professional boundaries: clinical judgment and patient medication counseling must be performed by the pharmacist, not the technician. Technicians must never offer medication counseling or exercise clinical judgment.
When a technician identifies an ambiguous abbreviation, dangerous dose notation, or unclear order, they must alert the pharmacist. The pharmacist can then exercise clinical judgment and resolve the issue with the prescriber.
Tall Man Lettering for Look-Alike, Sound-Alike Medications
Tall Man lettering uses capitalized letters within a drug name to highlight differences between look-alike, sound-alike medication names. By drawing immediate visual attention to the specific letters that distinguish two similar names, this strategy helps pharmacy staff avoid picking or typing the wrong medication. Both the Food and Drug Administration (FDA) and the Institute for Safe Medication Practices (ISMP) publish standard Tall Man lettering lists.
In daily practice, Tall Man lettering is applied to pharmacy computer order-entry screens, shelf labels, and automated dispensing cabinets. Spotting these capitalized letters during data entry and drug retrieval serves as an active visual warning to pause and confirm the selected product.
Specific pairs demonstrate why this lettering is vital. For example, buPROPion and busPIRone use Tall Man lettering to prevent confusion between an antidepressant and an anxiolytic. Similarly, predniSONE and predniSOLONE use Tall Man lettering to distinguish two similarly named corticosteroids whose usual anti-inflammatory doses are approximately equivalent. In oncology, vinBLAStine and vinCRIStine use Tall Man lettering to prevent fatal chemotherapy administration errors. In cardiovascular care, DOBUTamine and DOPamine use Tall Man lettering to distinguish different inotropic and vasopressor agents.
Other critical drug pairs require the same caution. cloNIDine and cloZAPine use Tall Man lettering to prevent mixing up an antihypertensive with an antipsychotic. metFORMIN and metroNIDAZOLE use Tall Man lettering to distinguish an oral antidiabetic agent from an antimicrobial agent. glyBURIDE and glipiZIDE differentiate two different sulfonylurea medications. hydrOXYzine and hydrALAZINE distinguish an antihistamine from an antihypertensive. Finally, fentaNYL and SUFentanil help differentiate opioids with different potencies.
| Tall Man Drug Pair | Therapeutic Difference or Clinical Purpose |
|---|---|
| buPROPion / busPIRone | Distinguishes an antidepressant from an anxiolytic |
| predniSONE / predniSOLONE | Distinguishes two corticosteroids (usual anti-inflammatory doses are approximately equivalent) |
| hydrOXYzine / hydrALAZINE | Distinguishes an antihistamine from an antihypertensive |
| vinBLAStine / vinCRIStine | Prevents fatal chemotherapy administration errors |
| DOBUTamine / DOPamine | Distinguishes different inotropic and vasopressor agents |
| cloNIDine / cloZAPine | Prevents mixing up an antihypertensive with an antipsychotic |
| metFORMIN / metroNIDAZOLE | Distinguishes an oral antidiabetic agent from an antimicrobial agent |
| glyBURIDE / glipiZIDE | Differentiates between two different sulfonylurea medications |
| fentaNYL / SUFentanil | Distinguishes opioids with different potencies |
Proper Dose Notations: Leading and Trailing Zeros
Decimal points in medication orders are easily overlooked or obscured, creating severe risks for patients. A leading zero must always be placed before a decimal point for medication values less than one, such as writing 0.5 mg. Writing 0.2 mg instead of .2 mg is a critical safety standard mandated by safety and accrediting organizations. Omitting a leading zero can cause a dose like .5 mg to be misread as 5 mg, leading to a potential ten-fold overdose.
Conversely, a trailing zero must never be written after a decimal point for whole numbers, such as writing 5 mg instead of 5.0 mg. A trailing zero can cause a dose like 5.0 mg to be misread as 50 mg if the decimal point is obscured or overlooked. Similarly, writing 10 mg instead of 10.0 mg reduces the risk that an overlooked decimal point will lead to a ten-fold overdose of 100 mg.
Due to these substantial dangers, leading regulatory and safety organizations enforce strict rules regarding decimal notations. The Joint Commission prohibits trailing zeros on medication orders in its official 'Do Not Use' list. Furthermore, the Institute for Safe Medication Practices designates both trailing zeros and naked decimal points as high-risk dose designations.
The Joint Commission Official 'Do Not Use' List
The Joint Commission requires accredited healthcare facilities to maintain and enforce a 'Do Not Use' list for dangerous abbreviations. Misinterpreted shorthand on prescriptions has directly caused dangerous patient errors, prompting strict standardization across healthcare facilities.
Dosing unit abbreviations present significant risks under this standard. The abbreviation 'U' or 'u' for unit is prohibited because it can be easily mistaken for the number '0', '4', or the abbreviation 'cc'. Prescriptions must spell out the word 'unit' instead of using the abbreviation 'U' or 'u'. Similarly, the abbreviation 'IU' for international unit is prohibited because it can be mistaken for 'IV' (intravenous) or the number '10'. When 'IU' means international units, write 'international units' in full; use 'units' only when that is the intended unit.
Dosing frequency abbreviations also lead to frequent misinterpretation. The abbreviations 'Q.D.', 'QD', 'q.d.', and 'qd' are prohibited because they are easily misread as 'QID' (four times daily). The term 'daily' must be written out completely rather than abbreviated as 'QD'. In the same way, the abbreviation 'Q.O.D.' or 'QOD' is prohibited because the 'O' can be misread as 'I', causing an every-other-day dose to be given four times daily. The phrase 'every other day' must be written out completely instead of using 'QOD'.
The Joint Commission's official 'Do Not Use' list prohibits the specific abbreviations MS, MSO4, and MgSO4; other drug name abbreviations may also be error-prone and should be avoided when they could cause confusion. The abbreviation 'MS' is prohibited because it can represent either morphine sulfate or magnesium sulfate. Furthermore, the chemical abbreviation 'MSO4' is prohibited because it can be mistaken for 'MgSO4', and 'MgSO4' is prohibited because it can be mistaken for 'MSO4'. Prescribers must write out 'morphine sulfate' and 'magnesium sulfate' in full to avoid lethal drug mix-ups.
ISMP List of Error-Prone Abbreviations, Symbols, and Dose Designations
The Institute for Safe Medication Practices maintains an extensive List of Error-Prone Abbreviations, Symbols, and Dose Designations. Technicians should recognize these problematic terms during data entry and prescription processing to alert the pharmacist whenever they appear.
Several volume and metric abbreviations are highly error-prone. The abbreviation 'cc' is error-prone because it can be misread as 'u' (units) or '00', and must be replaced with 'mL'. The microgram symbol 'µg' or abbreviation 'ug' can be mistaken for 'mg', creating the danger of a thousand-fold overdose. Healthcare providers should use 'mcg' or write out 'microgram' instead of using 'µg' or 'ug'. Additionally, apothecary units and symbols, such as drams and minims, should not be used in medication orders because they are prone to interpretation errors; metric system units such as mg, mcg, mL, and g should always be used instead of apothecary or household units.
Specific frequency, route, and medication abbreviations introduce further safety hazards. The abbreviation 'TIW' or 'tiw' (three times a week) is error-prone because it can be misread as 'TID' (three times a day); prescribers must write 'three times weekly' instead. The route abbreviation 'SQ' or 'sub q' is error-prone and should be written as 'subcut' or 'subcutaneously'. Drug name abbreviations like 'APAP' for acetaminophen and 'HCTZ' for hydrochlorothiazide are error-prone and should be avoided. The abbreviation 'MTX' is error-prone because it has been mistakenly confused with both methotrexate and mitoxantrone.
Common symbols and punctuation can also lead to misinterpretation. Using greater-than ('>') or less-than ('<') symbols can cause medication errors because they are easily confused with each other or numbers. The symbol '@' should not be used on prescriptions because it is easily misread as the number '2'. A slash mark ('/') between medication names or doses is discouraged because it can be misread as the number '1'. Finally, the abbreviation 'D/C' is ambiguous because it can mean either 'discontinue' a medication or 'discharge' a patient.
Common mistakes
- Failing to alert the pharmacist when finding ambiguous abbreviations, unclear orders, or dangerous dose notations, forgetting that technicians work under pharmacist supervision and cannot exercise clinical judgment.
- Writing a trailing zero after a whole number (such as writing 5.0 mg or 10.0 mg instead of 5 mg or 10 mg), which is prohibited by The Joint Commission and risks a ten-fold overdose of 50 mg or 100 mg if the decimal point is obscured.
- Omitting a leading zero for doses less than one (such as writing .5 mg or .2 mg instead of 0.5 mg or 0.2 mg), which ISMP designates as a high-risk dose designation that risks a ten-fold overdose.
- Using shorthand drug abbreviations like MS, MSO4, MgSO4, MTX, APAP, or HCTZ instead of writing out the full drug names, risking dangerous or lethal medication mix-ups.
Summary
- Pharmacy technicians work under pharmacist supervision, as required by state law, assisting in error prevention while the pharmacist performs clinical review, patient medication counseling, and final verification.
- When a technician identifies an ambiguous abbreviation, dangerous dose notation, or unclear order, they must alert the pharmacist.
- Tall Man lettering, published by the FDA and ISMP, capitalizes differing letters in look-alike, sound-alike drug names and is used on order-entry screens, shelf labels, and automated dispensing cabinets.
- A leading zero must always precede a decimal value less than one (e.g., 0.5 mg, 0.2 mg) to prevent ten-fold overdoses, whereas trailing zeros (e.g., 5.0 mg, 10.0 mg) are prohibited by The Joint Commission.
- The Joint Commission 'Do Not Use' list bans dangerous abbreviations including U, IU, QD, QOD, MS, MSO4, and MgSO4, requiring these terms and drug names to be spelled out in full.
- The ISMP List of Error-Prone Abbreviations, Symbols, and Dose Designations discourages abbreviations such as cc, µg, TIW, SQ, MTX, APAP, HCTZ, D/C, apothecary units (drams, minims), and symbols like >, <, @, and slashes.
Practice this section
Explained PTCE Patient Safety and Quality Assurance questions, no account needed. PTCE Patient Safety and Quality Assurance practice test
5 practice questions and 20 flashcards for this lesson are in your tests.global account.
Log in to use themThis is an open sample lesson. The full PTCE study guide (32 lessons so far) is included with PTCE plans, together with the practice question bank.
- 1 month
$44.99$22.49 - 3 months
$131.99$65.99 - Lifetime
$269.99$134.99
One payment, no subscription.
See PTCE plansAlready a member? Log in
25 practice questions on this exam
Each PTCE practice test has 25 original questions with the answers explained. No account needed.
Open the PTCE practice testsOriginal lesson written for PTCE practice · updated October 31, 2026. Exam names are trademarks of their owners; tests.global is not affiliated with them.